MR编号 | NL/H/2498/001 |
---|
药品名称 | Striverdi Respimat |
---|
活性成分 | |
---|
剂型 | Inhalation solution |
---|
上市许可持有人 | Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein
Germany |
---|
参考成员国 - 产品名称 | Netherlands (NL) Striverdi Respimat 2,5 microgram, inhalatieoplossing |
---|
互认成员国 - 产品名称 | - Germany (DE)
Striverdi Respimat 2,5 Mikrogramm/Hub Lösung zur Inhalation - Denmark (DK)
- Belgium (BE)
Striverdi Respimat - Luxembourg (LU)
- Iceland (IS)
Striverdi Respimat 2,5 míkróg Innöndunarlausn - United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Liechtenstein (LI)
- Austria (AT)
Striverdi Respimat 2,5 Mikrogramm - Lösung zur Inhalation - France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
Striverdi - Finland (FI)
- Poland (PL)
Striverdi Respimat - Latvia (LV)
- Lithuania (LT)
Striverdi Respimat 2,5 mikrogramo/išpurškime inhaliacinis tirpalas - Estonia (EE)
STRIVERDI RESPIMAT - Hungary (HU)
STRIVERDI RESPIMAT 2,5 mikrogramm inhalációs oldat - Bulgaria (BG)
Infortispir Respimat - Cyprus (CY)
Infortispir Respimat Inhalation solution - Czechia (CZ)
Striverdi Respimat 2,5 mikrogramů - Romania (RO)
Infortispir Respimat 2,5 micrograme soluţie de inhalat - Slovakia (SK)
Striverdi Respimat - Slovenia (SI)
- Malta (MT)
Striverdi Respimat 2.5mcg solution for inhalation
|
---|
许可日期 | 2013/09/04 |
---|
最近更新日期 | 2024/12/03 |
---|
药物ATC编码 | - R03AC Selective beta-2-adrenoreceptor agonists
|
---|
申请类型 | - TypeLevel1:New Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|